Hodgkin Lymphoma Clinical Trials
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
S
Recruiting
- Hodgkin Lymphoma
- brentuximab vedotin
- +5 more
- Fountain Valley, California
- +68 more
2022-01-07
Jan 7, 2022A
Not yet recruiting
- Hodgkin Lymphoma
- Non Hodgkin Lymphoma
- AB-205
- Placebo
- Duarte, California
- +7 more
2021-12-16
Dec 16, 2021C
F
Suspended
- Acute Leukemia
- +18 more
- Allogeneic Hematopoietic Stem Cell Transplantation
- +8 more
- Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
2021-12-16
Dec 16, 2021M
Recruiting
- Non-Hodgkin Lymphoma
- Hodgkin Lymphoma
- Etoposide
- +7 more
- Minneapolis, MinnesotaMasonic Cancer Center, University of Minnesota
2022-01-03
Jan 3, 2022U
Not yet recruiting
- Cancer
- +7 more
- Blood sampling
- Groningen, NetherlandsUniversity Medical Center Groningen
2022-01-04
Jan 4, 2022M
Recruiting
- Hodgkin Lymphoma
- pembrolizumab
- +9 more
- Birmingham, Alabama
- +83 more
2021-12-29
Dec 29, 2021A
Completed
- Hodgkin Lymphoma
- Non-hodgkin Lymphoma
- AB-205
- Duarte, California
- +8 more
2021-12-27
Dec 27, 2021R
Recruiting
- Melanoma
- +3 more
- Genetic tests of the available tumor and plasma samples
- Moscow', Москва, Russian FederationN.N. Blokhin Russian Cancer Research Center
2021-12-26
Dec 26, 2021A
Recruiting
- Hodgkin Lymphoma
- +2 more
- Patient registry
- Bergamo, ItalyHematology and Bone Marrow Transplant Unit, A.O. Ospedale Papa G
2021-12-22
Dec 22, 2021M
Not yet recruiting
- Central Nervous System Neoplasm
- +4 more
- Smartphone Application
- Houston, TexasM D Anderson Cancer Center
2021-12-22
Dec 22, 2021U
Recruiting
- Non-hodgkin Lymphoma
- +2 more
- Radiation - Dose Level 0
- +4 more
- Chicago, IllinoisUniversity of Chicago
2021-12-03
Dec 3, 2021N
Completed
- Leukemia
- +3 more
- Bethesda, MarylandNational Cancer Institute (NCI), 9000 Rockville Pike
2021-12-15
Dec 15, 2021T
Not yet recruiting
- Hodgkin Lymphoma
- No Intervention
- Wroclaw, Dolnoslskie, Poland
- +14 more
2021-12-14
Dec 14, 2021S
Recruiting
- Hodgkin Lymphoma
- +2 more
- brentuximab vedotin
- Anaheim, California
- +18 more
2021-12-10
Dec 10, 2021C
Recruiting
- Hematologic Malignancies
- +16 more
- A multicenter access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs)
- Birmingham, Alabama
- +138 more
2021-12-08
Dec 8, 2021S
Recruiting
- Hodgkin Lymphoma
- Denver, Colorado
- +5 more
2021-12-07
Dec 7, 2021P
A Phase II Study to Determine Pembrolizumab as Frontline Treatment of Patients With Hodgkin Lymphoma
Recruiting
- Hodgkin Lymphoma
- Concord, New South Wales, Australia
- +5 more
2021-12-05
Dec 5, 2021C
Recruiting
- Acute Myeloid Leukemia
- +6 more
- Donor Search Prognosis Score
- Duarte, California
- +51 more
2021-12-01
Dec 1, 2021N
Active, not recruiting
- Multiple Myeloma
- +4 more
- Total Body Irradiation
- +5 more
- Los Angeles, CaliforniaCedars Sinai Medical Center
2021-12-01
Dec 1, 2021M
Completed
- Acute Lymphocytic Leukemia
- +6 more
- Haploidentical Bone Marrow Transplant
- Double Umbilical Cord Blood Transplant
- Birmingham, Alabama
- +38 more
2021-11-02
Nov 2, 2021V
Recruiting
- Hodgkin Lymphoma
- +6 more
- Intravenous (IV) and oral Vitamin C
- Richmond, VirginiaVirginia Commonwealth University/ Massey Cancer Center
2021-11-30
Nov 30, 2021V
Recruiting
- Hodgkin Lymphoma
- +3 more
- Physical Activity Intervention (PAI)
- Healthy Living Control
- Richmond, Virginia
- +1 more
2021-11-29
Nov 29, 2021M
Recruiting
- Hodgkin Lymphoma
- Pembrolizumab
- Involved Site Radiation Therapy
- Miami, Florida
- +7 more
2021-11-23
Nov 23, 2021S
Completed
- Hodgkin Lymphoma
- 12 Week Stanford V Chemotherapy
- +3 more
- Palo Alto, California
- +4 more
2021-11-23
Nov 23, 2021